Clinical Trial: The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional
Official Title: The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Brief Summary: To find the safe effective lowest light dose for photodynamic therapy (PDT). in the treatment of central serous chorioretinopathy.
Detailed Summary:
Sponsor: Yeungnam University College of Medicine
Current Primary Outcome: Changes of best corrected visual acuity [ Time Frame: 6 month ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Change of central retinal thickness, success rate, recurrence rate, and complications [ Time Frame: 6 months ]
Original Secondary Outcome: Same as current
Information By: Yeungnam University College of Medicine
Dates:
Date Received: June 26, 2012
Date Started: June 2012
Date Completion: March 2015
Last Updated: February 13, 2015
Last Verified: February 2015